ArticleScientific reports2025
Exploring market-approved azoles as potential breast cancer therapeutics targeting the VEGFR-2 biotarget.
Asmaa M Atta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it